
5 Ways the US Obesity Landscape Strays From the Global Picture
As obesity prevalence continues to rise, the US remains a leader in clinical research and drug development, yet it stands apart in key ways from its global counterparts. Novotech’s “Obesity: Global Clinical Trial Landscape (2025)” report detailed how the …